Lehtinen, Matti

Cross-protection is crucial for prophylactic HPV vaccination. [electronic resource] - The Lancet. Infectious diseases Oct 2012 - 742-3 p. digital

Publication Type: Letter; Comment

1474-4457

10.1016/S1473-3099(12)70203-7 doi


Cross Protection
Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18
Humans
Papillomavirus Infections--prevention & control
Papillomavirus Vaccines--immunology